Table 2.
Case number | Gender | Age, years | Disease course | Disease duration, months | Number of tissue sections | Number of lesions | Early-active regions | Late-active regions | Inactive regions | Periplaque WM regions |
---|---|---|---|---|---|---|---|---|---|---|
1 | F | 47 | Acute | 3.5 | 2 | 3 | 3 | 2 | 2 | 2 |
2 | F | 46 | Acute | 0.4 | 3 | 4 | 4 | 4 | 4 | 3 |
3 | F | 28 | SP | 12 | 2 | 7 | 6 | 4 | 3 | 2 |
4 | M | 52 | Acute | 1.5 | 2 | 7 | 6 | 3 | 2 | 2 |
5 | F | 34 | SP | 144 | 1 | 2 | 2 | 2 | 2 | 1 |
5 Patients | 4F/1M | 41 (28–52) | 3 Acute/2 SP | 32.3 (0.4–144) | 10 | 23 | 21 | 15 | 13 | 10 |
F, female; M, male; SP, secondary progressive; WM, white matter.